Monographie - Amphotericin B lipid complex

Poslední aktualizace :
19/11/2024

Amphotericin B lipid complex

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abelcet

Airija, Argentina, Australija, Austrija, Belgija, Brazilija, Danija, Didžioji Britanija, Graikija, Ispanija, Italija, Jungtinės Amerikos Valstijos, Kanada, Liuksemburgas, Malaizija, Meksikas, Norvegija, Olandija, Peru, Portugalija, Prancūzija, Rumunija, Suomija, Švedija, Vengrija, Vokietija

Bibliografija : Amphotericin B lipid complex

	tipas	leidinys
1510	Knyga	AHFS Formulary service 2000 Bethesda - 3546 p
2247	Žurnalas	Chan P, Heatherly K, Kupiec T.C, Trissel L.A. Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262	Žurnalas	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254	Žurnalas	Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332	Laboratorija	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3644	Laboratorija	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3828	plakatas	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakatas	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Žurnalas	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44

Mentions Légales